Nisa Investment Advisors, LLC Repligen Corp Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 380 shares of RGEN stock, worth $47,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
380
Previous 480 20.83%
Holding current value
$47,397
Previous $60,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$119.79 - $167.35 $11,979 - $16,735
-100 Reduced 20.83%
380 $56,000
Q2 2024

Jul 19, 2024
SELL
$120.0 - $182.95 $59,400 - $90,560
-495 Reduced 50.77%
480 $60,000
Q1 2024

May 01, 2024
BUY
$170.78 - $208.42 $11,100 - $13,547
65 Added 7.14%
975 $179,000
Q4 2023

Jan 25, 2024
BUY
$114.17 - $185.35 $43,042 - $69,876
377 Added 70.73%
910 $163,000
Q3 2023

Nov 02, 2023
BUY
$138.78 - $176.51 $29,837 - $37,949
215 Added 67.61%
533 $84,000
Q2 2023

Aug 11, 2023
SELL
$138.42 - $180.31 $69,763 - $90,876
-504 Reduced 61.31%
318 $44,000
Q1 2023

May 02, 2023
BUY
$154.26 - $198.1 $77,592 - $99,644
503 Added 157.68%
822 $138,000
Q3 2022

Nov 07, 2022
SELL
$160.42 - $256.21 $15,239 - $24,339
-95 Reduced 22.95%
319 $58,000
Q2 2022

Aug 03, 2022
SELL
$140.68 - $188.02 $42,204 - $56,406
-300 Reduced 42.02%
414 $67,000
Q1 2022

Apr 29, 2022
SELL
$161.19 - $257.96 $242,429 - $387,971
-1,504 Reduced 67.81%
714 $134,000
Q4 2021

Feb 03, 2022
BUY
$247.59 - $304.47 $20,549 - $25,271
83 Added 3.89%
2,218 $440,000
Q3 2021

Oct 18, 2021
SELL
$194.77 - $324.21 $423,040 - $704,184
-2,172 Reduced 50.43%
2,135 $617,000
Q2 2021

Aug 06, 2021
SELL
$165.87 - $220.95 $16,587 - $22,095
-100 Reduced 2.27%
4,307 $860,000
Q1 2021

Apr 26, 2021
BUY
$180.37 - $226.26 $72,148 - $90,504
400 Added 9.98%
4,407 $857,000
Q4 2020

Jan 25, 2021
BUY
$148.08 - $206.57 $177,251 - $247,264
1,197 Added 42.6%
4,007 $768,000
Q3 2020

Oct 20, 2020
SELL
$122.51 - $158.27 $430,255 - $555,844
-3,512 Reduced 55.55%
2,810 $415,000
Q2 2020

Jul 27, 2020
BUY
$94.33 - $140.48 $560,508 - $834,732
5,942 Added 1563.68%
6,322 $781,000
Q1 2020

Apr 17, 2020
SELL
$84.96 - $109.14 $7,646 - $9,822
-90 Reduced 19.15%
380 $37,000
Q4 2019

Jan 17, 2020
BUY
$73.84 - $93.08 $13,291 - $16,754
180 Added 62.07%
470 $43,000
Q3 2019

Oct 17, 2019
BUY
$76.65 - $95.51 $6,898 - $8,595
90 Added 45.0%
290 $22,000
Q1 2019

Apr 17, 2019
BUY
$49.45 - $62.8 $9,890 - $12,560
200 New
200 $12,000
Q1 2018

Apr 10, 2018
SELL
$30.92 - $37.27 $12,986 - $15,653
-420 Closed
0 $0
Q3 2017

Oct 13, 2017
BUY
$36.98 - $46.06 $15,531 - $19,345
420
420 $16,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email